Pay in 4 interest-free payments of $5.38 Learn more
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13
Brown JM, Ball JG, Hogsett A, et al
Inhibition of ALK is a target for slowing proliferation in NSCLC
A licensed clinician should weigh any decision involving an unapproved research compound
When we look at our own results, it is seen that the levels of Threonine, Aspartate, and Arginine levels are significantly reduced
In summary, the core breakthrough in current HIF-targeted drug development lies in establishing the regulation of ROS generation (inhibiting pathological accumulation or controllably utilizing its killing effect) as the key hub for intervening in hypoxia-related diseases
Figure S9
US$ 26.58
US$ 20.45
US$ 21.46
US$ 20.72
